Barbarosh Craig A. 4

What Happened

• Craig A. Barbarosh, a director of Evolent Health, was granted 41,096 restricted stock units (RSUs) on June 4, 2026. The Form 4 reports an acquisition (Award/Grant, code A) at a per-share price of $0.00 (total reported cost $0).
• This is a grant of equity compensation (not a market purchase or sale) and does not represent an immediate cash transaction or sale of shares.

Key Details

• Transaction date: June 4, 2026; Form 4 filed June 8, 2026 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 41,096 RSUs; reported price $0.00 (total $0 as reported).
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 — grant under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 — RSUs vest on the earlier of June 4, 2027 or the company’s 2027 annual meeting, subject to continued service.

Context

• RSU grants vest in the future and typically encourage continued service; they are not an immediate buy or sell signal. The award will convert to shares only if and when the vesting conditions are met.